FDA.reportPublic FDA data

golimumab 100 MG in 1 ML Prefilled Syringe

RxCUI
1482813
RxNorm name
golimumab 100 MG in 1 ML Prefilled Syringe
Display name
golimumab 100 MG in 1 ML Prefilled Syringe
Full name
golimumab 100 MG in 1 ML Prefilled Syringe
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:28

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125289Simponigolimumab351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
f86cb4a7-c358-4136-ae57-b32bda9bba00golimumab 100 MG in 1 ML Prefilled Syringe [PSN] · 1 ML golimumab 100 MG/ML Prefilled Syringe [SCD] · golimumab 100 MG per 1 ML Prefilled Syringe [SY]342These highlights do not include all the information needed to use SIMPONI safely and effectively. See full prescribing information for SIMPONI. SIMPONI ® (golimumab) injection, for subcutaneous use Initial U.S. Approval: 200920251029